Stocks and Investing
Stocks and Investing
Mon, March 9, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sun, March 8, 2020
[ 12:00 AM ] - United States, WOPRAI
Fri, March 6, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Neena Bitritto-Garg Initiated (ACAD) at Strong Buy and Held Target at $69 on, Mar 6th, 2020
Neena Bitritto-Garg of Citigroup, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy and Held Target at $69 on, Mar 6th, 2020.
Neena has made no other calls on ACAD in the last 4 months.
There are 2 other peers that have a rating on ACAD. Out of the 2 peers that are also analyzing ACAD, 0 agree with Neena's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Neena
- Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $75 on, Thursday, February 27th, 2020
- Yatin Suneja of "Guggenheim" Initiated at Strong Buy and Held Target at $60 on, Monday, December 16th, 2019
Contributing Sources